Canid Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
47
- Latest Deal Type
-
Series A1
- Latest Deal Amount
-
$13.4M
- Investors
-
15
Canid General Information
Description
Developer of a healthcare dashboard and process tool intended to simplify vaccination record management. The company's tool offers administrative consulting, secures vaccine margins, automates your vaccine workflow, and oversees vaccine inventory, enabling state officials and pediatric practitioners to focus on their day-to-day practice.
Contact Information
Website
www.canid.ioCorporate Office
- 215 East 24th Street
- Suite 315, Manhattan
- New York, NY 10010
- United States
Corporate Office
- 215 East 24th Street
- Suite 315, Manhattan
- New York, NY 10010
- United States
Canid Timeline
Canid Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC (Series A1) | 03-Jun-2025 | $13.4M | Completed | Generating Revenue | ||
| 3. Early Stage VC (Series A) | 21-Sep-2023 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 01-Jul-2022 | $500K | $1.5M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 12-Mar-2021 | $1M | $1M | Completed | Generating Revenue |
Canid Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A-4 | ||||||||
| Series A-3 | 751,124 | $0.000100 | $0.91 | $0.91 | 1x | $0.91 | 7.49% | |
| Series A-2 | 1,409,729 | $0.000100 | $0.71 | $0.71 | 1x | $0.71 | 14.05% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Canid Comparisons
Industry
Financing
Details
Canid Competitors (2)
One of Canid’s 2 competitors is Color, a Venture Capital-Backed company based in Burlingame, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Color | Venture Capital-Backed | Burlingame, CA | ||||
| VaxCare | Private Equity-Backed | Orlando, FL |
Canid Signals
Canid Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| OnDeck | Corporation | Minority | ||
| Telescope Partners | Growth/Expansion | Minority | ||
| Angel (individual) | Minority | |||
| Angel (individual) | Minority | |||
| MKT1 | Venture Capital | Minority |
Canid FAQs
-
When was Canid founded?
Canid was founded in 2020.
-
Where is Canid headquartered?
Canid is headquartered in New York, NY.
-
What is the size of Canid?
Canid has 47 total employees.
-
What industry is Canid in?
Canid’s primary industry is Practice Management (Healthcare).
-
Is Canid a private or public company?
Canid is a Private company.
-
What is the current valuation of Canid?
The current valuation of Canid is .
-
What is Canid’s current revenue?
The current revenue for Canid is .
-
How much funding has Canid raised over time?
Canid has raised $16.4M.
-
Who are Canid’s investors?
OnDeck, Telescope Partners, , , and MKT1 are 5 of 15 investors who have invested in Canid.
-
Who are Canid’s competitors?
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process